Stelac Advisory Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,920
Closed -$114K 179
2026
Q1
$114K Buy
+20,920
New +$117K 0.02% 153
2021
Q3
Sell
-636
Closed -$106K 274
2021
Q2
$106K Sell
636
-163
-20% -$26.4K 0.02% 278
2021
Q1
$145K Buy
799
+45
+6% +$10.4K 0.05% 180
2020
Q4
$151K Buy
+754
New +$153K 0.04% 203

Other funds holding TDOC

Stelac Advisory Services's TDOC Position: Q2 2026 in Review

Stelac Advisory Services sold out of Teladoc Health (TDOC) in Q2 2026, closing a stake of 20,920 shares — an estimated $114K sold.

Stelac Advisory Services first reported a position in TDOC in Q4 2020 and held it in 4 quarters. The position peaked at $151K in Q4 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Stelac Advisory Services reported no remaining Teladoc Health position as of Q2 2026 after selling out during the quarter.
  • Stelac Advisory Services sold 20,920 Teladoc Health shares in Q2 2026, an estimated $114K.
  • Stelac Advisory Services first reported a position in Teladoc Health in Q4 2020 and held it in 4 quarters.
  • Stelac Advisory Services's Teladoc Health position peaked at $151K in Q4 2020.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Stelac Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.